Biodexa Pharmaceuticals Plc (BDRX)
1.30
+0.58
(+79.36%)
USD |
NASDAQ |
Apr 26, 16:00
1.21
-0.09
(-6.92%)
After-Hours: 20:00
Biodexa Pharmaceuticals Total Liabilities (Quarterly): 7.470M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 7.470M |
| June 30, 2023 | 3.358M |
| June 30, 2023 | 3.358M |
| December 31, 2022 | 2.859M |
| June 30, 2022 | 2.657M |
| June 30, 2022 | 2.657M |
| December 31, 2021 | 3.321M |
| June 30, 2021 | 6.259M |
| June 30, 2021 | 6.259M |
| December 31, 2020 | 4.223M |
| June 30, 2020 | 9.170M |
| June 30, 2020 | 9.170M |
| December 31, 2019 | 14.86M |
| June 30, 2019 | 4.794M |
| Date | Value |
|---|---|
| June 30, 2019 | 4.794M |
| December 31, 2018 | 4.466M |
| June 30, 2018 | 16.31M |
| June 30, 2018 | 16.31M |
| December 31, 2017 | 19.66M |
| June 30, 2017 | 11.02M |
| June 30, 2017 | 11.02M |
| December 31, 2016 | 13.47M |
| June 30, 2016 | 21.37M |
| June 30, 2016 | 21.37M |
| December 31, 2015 | 25.41M |
| June 30, 2015 | 8.083M |
| June 30, 2015 | 8.083M |
| December 31, 2014 | 7.275M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
2.657M
Minimum
Jun 2022
14.86M
Maximum
Dec 2019
5.681M
Average
4.794M
Median
Jun 2019
Total Liabilities (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 243.10M |
| NuCana PLC | 16.46M |
| Autolus Therapeutics PLC | 263.91M |
| Mereo BioPharma Group PLC | 15.96M |
| Bicycle Therapeutics PLC | 224.41M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 13.43M |
| Shareholders Equity (Quarterly) | 5.959M |
| Current Ratio | 1.262 |